Literature DB >> 25357159

Risk factors for reexploration in toe-to-hand transfer: a multivariate analysis of 363 cases.

Yu-Te Lin1, Shiuan-Tzuen Su, Steven Lo, Ching-Hsuan Hu, Chih-Hung Lin, Fu-Chan Wei.   

Abstract

BACKGROUND: Reexploration after toe-to-hand transfer increases the risk of failure. In this study, the authors aimed to identify risk factors for reexploration after toe-to-hand transfer.
METHODS: The medical records of 363 patients who underwent single toe-to-hand transfer between 2000 and 2010 were reviewed retrospectively. Patient demographics, clinical data, and operative data were collected, and multivariate analysis was performed.
RESULTS: Of these 363 patients, 299 toes (82.4 percent) had primary success in transplantation. Sixty-four toes required reexploration, of which seven toes failed. The overall success rate was 98.1 percent. Of the 64 toes that required reexploration, arterial spasm was found in 39 (60.9 percent), arterial thrombosis was found in 27 (42.2 percent), and venous thrombosis was found in 16 (25.0 percent). Multivariate logistic regression analysis revealed that postoperative wound infection, metacarpal hand injuries, and preceding flap coverage were independently associated with reexploration.
CONCLUSIONS: Reducing reexploration in toe-to-hand transfer may be facilitated by managing or avoiding these risk factors. Particular attention must be paid to avoid postoperative wound infection, which was the single greatest factor contributing to reexploration (adjusted OR, 12.6). CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

Entities:  

Mesh:

Year:  2015        PMID: 25357159     DOI: 10.1097/PRS.0000000000000884

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  1 in total

1.  Reconstruction of the Foot and Ankle Using Pedicled or Free Flaps: Perioperative Flap Survival Analysis.

Authors:  Xiucun Li; Jianli Cui; Suraj Maharjan; Laijin Lu; Xu Gong
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.